Neurology Minute
Summary: The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
- Visit Website
- RSS
- Artist: American Academy of Neurology
- Copyright: 2019
Podcasts:
Dr. Jonathan Graff-Radford discusses highlights of the upcoming AAN Fall Conference in Las Vegas.
Dr. Jonathan Newmark discusses the main takeaways on acute nerve agent poisoning.
Dr. Jan Claassen discusses the main takeaways from his NEJM paper on detection of brain activation in unresponsive patients with acute brain injury.
Dr. Jason Crowell discusses important changes to the CMS' new proposed payment rule.
Dr. Elan Louis discusses tremor in the third part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
Dr. Elan Louis discusses tremor in the second part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
Dr. Bernard Hemmer discusses the main takeaways from his paper on vaccination as risk factor for multiple sclerosis.
Dr. Amanda Grenell discusses the main takeaways from her Zika virus update.
Dr. Jason Crowell highlights a commentary in Neurology: Clinical Practice on the imposter phenomenon and advancing women in neurology practice. You can read the commentary here: https://cp.neurology.org/content/9/2/155.
Dr. Jeff Ratliff discusses FDA approval of new sIRNA therapies.
Dr. Elan Louis discusses tremor in the first part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
Dr. Anastasia Zekeridou discusses the main takeaways from her paper on a new paraneoplastic biomarker.
Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.
Dr. David Lapides discusses management of measles vaccination in immuno-suppressed patients.
Dr. Ross Tingen discusses recent data surrounding IgG levels and MS.
